Latest Bladder Cancer News
As of 2014, rate is 16.8% but big socioeconomic disparities remain.
Use of the Moreau substrain, aimed at easing a worldwide BCG shortage, is associated with 5-year outcomes similar to those of other substrains.
The procedure takes longer than open radical cystectomy, but is associated with less blood loss, fewer transfusions, and shorter hospital stays.
The syndrome is associated with a significant 2-fold increased risk of urothelial carcinoma of the bladder.
Those inhaling the lowest levels of the addictive agent were more likely to try to stop.
Odds for the disease climbing faster among women than men in the workforce.
Researchers report a significant drop in 30-day post-operative infection rate.
In a small study, 56% of NMIBC patients who received the dual regimen after failing treatment with BCG alone were tumor free.
Cisplatin-based chemotherapy after radical cystectomy for high-risk bladder cancer decreased the risk of death from the malignancy by 29%.
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
Population-based Australian data from 2001-2009 show better 5-year disease-specific and overall survival rates compared with older studies.
Computed tomography (CT) scans prior to radical cystectomy for invasive bladder cancer may be useful.
The malignancy is 36% less likely to develop, after adjusting for age and smoking, data show.
IsoFlux test showed 10 or more circulating tumor cells in four of nine samples, versus 0 with CellSearch.
New data suggest a prognosis role for the neutrophil to lymphocyte ratio.
Bladder Cancer Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)